The National Pharmaceutical Council published a recent study on principles it says should guide when it is and is not acceptable for patients with the same condition to pay different out-of-pocket (OOP) costs. The study identified five guiding principles to determine when it was more or less acceptable for patients to have different OOP costs, which included when patients have tried lower-cost therapies unsuccessfully and knowing that the benefits of higher-cost treatments were certain. However, the study noted that barriers that hinder alignment of care and patient cost sharing still exist and policies that facilitate this alignment are needed. Click here to read more.
Last Updated on May 12, 2020 by Aimed Alliance
